Your Sorted CME/CE Activities

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma
Certified CME/CNE Web Archive
Treatment paradigms for multiple myeloma have changed substantially over the last years with many advances in novel therapeutic approaches.

Presented by Dr. Joseph Mikhael of the Translational Genomics Research Institute, City of Hope Cancer Center, and Chief Medical Officer of the International Myeloma Foundation, the archived recording of the certified-CME/CNE 1-hour live webcast will cover recent updates in the standard of care and review the latest approved products and new research for the management of multiple myeloma.
Review the archive and claim AMA, or ANCC credit/contact hour(s) after completion of the brief Post-Test/Evaluations.



 

Joseph Mikhael, MD, MEd, FRCPC, FACP Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor, Applied Cancer Research and Drug Discovery,
Translational Genomics Research Institute (TGen),
City of Hope Cancer Center
Chief Medical Officer, International Myeloma Foundation
Consultant Hematologist and Director, Myeloma Research, Phase 1 Program,
HonorHealth Research Institute
Adjunct Professor, College of Health Solutions,
Arizona State University
 

20
Supported by independent educational grants from GlaxoSmithKline, LLC and Karyopharm Therapeutics Inc.

Launch Date: October 1, 2020
Release Date: September 30, 2020
Expiration Date: August 31, 2021

August 30, 2021
Mini Module
6844
MultipleMyeloma_WebBanner(1150).gif
Hem-Onc